Ftse Mib
37.055,70
-0,18%
DAX
21.787,00
-0,58%
S&P 500
6.025,99
-0,95%
NASDAQ
19.523,40
-1,36%
Bitcoin
96.239,80
-0,23%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anika Therapeutics Inc (ANIK) Anika Therapeutics Inc (ANIK) Notizie

ANIK

Anika Therapeutics (ANIK)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANIK
DataOraFonteTitoloSimboloCompagnia
23/12/202422:01GlobeNewswire Inc.Anika To Participate in 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
22/11/202422:16GlobeNewswire Inc.Anika To Participate in December 2024 Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
08/11/202420:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
04/11/202422:41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
31/10/202416:00PR Newswire (US)Arthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsNASDAQ:ANIKAnika Therapeutics Inc
31/10/202412:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
31/10/202412:05GlobeNewswire Inc.Anika Reports Third Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
31/10/202412:00GlobeNewswire Inc.Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus MedicalNASDAQ:ANIKAnika Therapeutics Inc
17/10/202422:01GlobeNewswire Inc.Anika Announces Third Quarter 2024 Results Conference Call DateNASDAQ:ANIKAnika Therapeutics Inc
04/10/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
04/10/202422:01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
08/08/202422:05GlobeNewswire Inc.Anika Reports Second Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
05/08/202422:01GlobeNewswire Inc.Anika to Participate in the Sidoti Virtual Investor ConferenceNASDAQ:ANIKAnika Therapeutics Inc
25/07/202415:00GlobeNewswire Inc.Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
11/07/202414:30GlobeNewswire Inc.Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon RepairsNASDAQ:ANIKAnika Therapeutics Inc
11/06/202423:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ANIKAnika Therapeutics Inc
11/06/202423:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIKAnika Therapeutics Inc
05/06/202422:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
30/05/202422:31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/05/202422:05GlobeNewswire Inc.Anika Enters into Cooperation Agreement with Caligan PartnersNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422:08GlobeNewswire Inc.Anika Announces CFO TransitionNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422:05GlobeNewswire Inc.Anika Reports First Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
18/04/202422:01GlobeNewswire Inc.Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
02/04/202414:00GlobeNewswire Inc.Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
13/03/202421:05GlobeNewswire Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
13/03/202412:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:ANIKAnika Therapeutics Inc
27/02/202422:01GlobeNewswire Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:ANIKAnika Therapeutics Inc
13/02/202415:00GlobeNewswire Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
09/02/202417:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
22/01/202415:29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ANIKAnika Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANIK

La tua Cronologia

BIT
BPE
Bper Banca
BIT
IVG
Iveco Group NV
BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
BPSO
Banca Popolare di Sondrio
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
NEXI
Nexi S.p.A
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci